Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

Gizal Nakshbandi; Catharina C Moor; Kerri A Johannson; Toby M Maher; Michael Kreuter; Marlies S Wijsenbeek

doi:10.1183/23120541.00405-2021

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

ERJ Open Res. 2021 Aug 31;7(3):00405-2021. doi: 10.1183/23120541.00405-2021. eCollection 2021 Jul.

Authors

Gizal Nakshbandi¹, Catharina C Moor¹, Kerri A Johannson², Toby M Maher³, Michael Kreuter⁴, Marlies S Wijsenbeek¹

Affiliations

¹ Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
² Dept of Medicine, University of Calgary, Calgary, Canada.
³ Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
⁴ Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Germany and German Center for Lung Research, Heidelberg, Germany.

Abstract

The #COVID19 pandemic has led to an increase in the use of eHealth for patients with interstitial lung disease. Healthcare providers worldwide are positive towards further implementation of eHealth for research and clinical practice. https://bit.ly/3h2545M.